The intersection between HIV and syphilis in men who have sex with men: Some fresh perspectives

HIV Therapy

Volumn 4, Issue 6, 2010, Pages 661-673

  Drummond, Fraser ^a,b   Guy, Rebecca ^a   Kaldor, John M ^a   Donovan, Basil ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY EYE HOSPITAL   (Australia)

Author keywords

diagnosis; HIV; management; men who have sex with men; prevention; syphilis

Indexed keywords

AMOXICILLIN; ANTIRETROVIRUS AGENT; AZITHROMYCIN; BENZATHINE PENICILLIN; BENZATHINE PENICILLIN PLUS AMOXICILLIN; DOXYCYCLINE; PENICILLIN G; PROBENECID; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; ANUS INTERCOURSE; ATTITUDE TO HEALTH; AWARENESS; BEHAVIOR; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CHEMOPROPHYLAXIS; CHLAMYDIASIS; CONDOM; CONTACT EXAMINATION; DIAGNOSTIC PROCEDURE; EPIDEMIC; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RISK; LEUKOCYTE COUNT; LUMBAR PUNCTURE; MALE HOMOSEXUAL; MEDICAL CARE; NEUROSYPHILIS; ORAL SEXUAL CONTACT; REVIEW; SEXUAL BEHAVIOR; SINGLE DRUG DOSE; SYPHILIS; TREATMENT RESPONSE; VIRUS LOAD;

EID: 78650571151     PISSN: 17584310     EISSN: None     Source Type: Journal    
DOI: 10.2217/hiv.10.55     Document Type: Review

References (108)

1. Dowell D, Polgreen PM, Beekmann SE, Workowski KA, Berman SM, Peterman TA: Dilemmas in the management of syphilis: a survey of infectious diseases experts. Clin. Infect. Dis. 49(10), 1526-1529 (2009).
2. Centers for Disease Control and Prevention (CDC): Primary and secondary syphilis - United States, 2000-2001. MMWR Morb. Mortal. Wkly Rep. 51(43), 971-973 (2002).
3. Righarts AA, Simms I, Wallace L, Solomou M, Fenton KA: Syphilis surveillance and epidemiology in the United Kingdom. Euro Surveill. 9(12), 21-25 (2004).
4. Jin F, Prestage GP, Kippax SC et al.: Epidemic syphilis among homosexually active men in Sydney. Med. J. Aust. 183(4), 179-183 (2005).
5. Centers for Disease Control and Prevention (CDC):Primary and secondary syphilis - United States, 2003-2004. MMWR Morb Mortal Wkly Rep 55(10), 269-273 (2006).
6. Klausner JD, Kent CK, Wong W, McCright J, Katz MH: The public health response to epidemic syphilis, San Francisco, 1999-2004. Sex. Transm. Dis. 32(Suppl. 10), S11-S18 (2005).
7. Jin F, Prestage GP, Zablotska I et al.: High incidence of syphilis in HIV-positive homosexual men: data from two community-based cohort studies. Sex. Health 6(4), 281-284 (2009).
8. Elford J: Changing patterns of sexual behaviour in the era of highly active antiretroviral therapy. Curr. Opin. Infect. Dis. 19(1), 26-32 (2006).
9. Dougan S, Evans BG, Elford J: Sexually transmitted infections in Western Europe among HIV-positive men who have sex with men. Sex. Transm. Dis. 34(10), 783-790 (2007). (Pubitemid 47463839)
10. Velter A, Bouyssou-Michel A, Arnaud A, Semaille C: Do men who have sex with men use serosorting with casual partners in France? Results of a nationwide survey (ANRS-EN17-Presse Gay 2004). Euro. Surveill. 14(47), (2009).
11. Jin F, Crawford J, Prestage GP et al.: Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS 23(2), 243-252 (2009). Excellent ana lysis looking at various risk-reduction strategies used by men who have sex with men (MSM) and their risks of HIV acquisition.
12. Golden MR, Stekler J, Hughes JP, Wood RW: HIV serosorting in men who have sex with men: is it safe? J. Acquir. Immune Defic. Syndr. 49(2), 212-218 (2008).
13. Zablotska IB, Imrie J, Prestage G et al.: Gay men's current practice of HIV seroconcordant unprotected anal intercourse: serosorting or seroguessing? AIDS Care 21(4), 501-510 (2009).
14. Wilson DP, Regan DG, Heymer KJ, Jin F, Prestage GP, Grulich AE: Serosorting may increase the risk of HIV acquisition among men who have sex with men. Sex. Transm. Dis. 37(1), 13-17 (2010). Modeling work on the possible effects of serosorting on HIV acquisition rates.
15. Crepaz N, Marks G, Liau A et al.: Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: a meta-ana lysis. AIDS 23(13), 1617-1629 (2009).
16. Thurnheer MC, Weber R, Toutous-Trellu L et al.: Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study. AIDS 24(12), 1907-1916 (2010). Excellent review of syphilis in a national cohort of HIV-infected patients.
17. Phipps W, Kent CK, Kohn R, Klausner JD: Risk factors for repeat syphilis in men who have sex with men, San Francisco. Sex. Transm. Dis. 36(6), 331-335 (2009).
18. Marcus U, Bremer V, Hamouda O et al.: Understanding recent increases in the incidence of sexually transmitted infections in men having sex with men: changes in risk behavior from risk avoidance to risk reduction. Sex. Transm. Dis. 33(1), 11-17 (2006).
19. Mehta SD, Ghanem KG, Rompalo AM, Erbelding EJ: HIV seroconversion among public sexually transmitted disease clinic patients: ana lysis of risks to facilitate early identification. J. Acquir. Immune Defic. Syndr. 42(1), 116-122 (2006).
20. Sellati TJ, Wilkinson DA, Sheffield JS, Koup RA, Radolf JD, Norgard MV: Virulent Treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1. J. Infect. Dis. 181(1), 283-293 (2000).
21. Beyrer C: Global prevention of HIV infection for neglected populations: men who have sex with men. Clin. Infect. Dis. 50(S3), S108-S113 (2010).
22. Hart G: Syphilis tests in diagnostic and therapeutic decision making. Ann. Intern. Med. 104(3), 368-376 (1986). Thorough overview of diagnostic testing for syphilis.
23. Sena AC, White BL, Sparling PF: Novel treponema pallidum serologic tests: a paradigm shift in Syphilis screening for the 21st Century. Clin. Infect. Dis. 51(6), 700-708 (2010). Discussion of implications on changing syphilis screening from nontreponemal to treponemal tests to screen for syphilis.
24. Mishra S, Boily MC, Ng V et al.: The laboratory impact of changing syphilis screening from the rapid-plasma reagin to a treponemal enzyme immunoassay: a case-study from the greater toronto area. Sex. Transm. Dis. DOI: 10.1097/OLQ.0b013e3181f07e91 (2010) (Epub ahead of print).
25. Lautenschlager S: Diagnosis of syphilis: clinical and laboratory problems. J. Dtsch Dermatol. Ges. 4(12), 1058-1075 (2006).
26. Rogstad KE, Simms I, Fenton KA, Edwards S, Fisher M, Carne CA: Screening, diagnosis and management of early syphilis in genitourinary medicine clinics in the UK. Int. J. STD AIDS 16(5), 348-352 (2005).
27. Leslie DE, Azzato F, Karapanagiotidis T, Leydon J, Fyfe J: Development of a real-time PCR assay to detect Treponema pallidum in clinical specimens and assessment of the assay's performance by comparison with serological testing. J. Clin. Microbiol. 45(1), 93-96 (2007).
28. Heymans R, van der Helm JJ, de Vries HJ, Fennema HS, Coutinho RA, Bruisten SM: Clinical value of Treponema pallidum real-time PCR for diagnosis of syphilis. J. Clin. Microbiol. 48(2), 497-502 (2010).
29. Horberg MA, Ranatunga DK, Quesenberry CP, Klein DB, Silverberg MJ: Syphilis epidemiology and clinical outcomes in HIV-infected and HIV-uninfected patients in Kaiser Permanente Northern California. Sex. Transm. Dis. 37(1), 53-58 (2010).
30. Hopkins S, Bergin C, Mulcahy F: HIV status does not contribute to response to syphilis treatment. Int. J. STD AIDS 20(8), 593, author reply 593-594 (2009).
31. Manavi K, McMillan A: The outcome of treatment of early latent syphilis and syphilis with undetermined duration in HIV-infected and HIV-uninfected patients. Int. J. STD AIDS 18(12), 814-818 (2007).
32. Warwick Z, Dean G, Fisher M: Should syphilis be treated differently in HIV-positive and HIV-negative individuals? Treatment outcomes at a university hospital, Brighton, UK. Int. J. STD AIDS 20(4), 229-230 (2009).
33. French P: Syphilis. BMJ 334(7585), 143-147 (2007). Excellent review of syphilis and its consequences.
34. Golden MR, Marra CM, Holmes KK: Update on syphilis: resurgence of an old problem. JAMA 290(11), 1510-1514 (2003).
35. Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM: Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex. Transm. Infect. 83(2), 97-101 (2007).
36. Manfredi R, Sabbatani S, Pocaterra D, Calza L, Chiodo F: Syphilis does not seem to involve virological and immunological course of concurrent HIV disease. AIDS 20(2), 305-306 (2006).
37. Zetola NM, Klausner JD: Syphilis and HIV infection: an update. Clin. Infect. Dis. 44(9), 1222-1228 (2007).
38. Workowski KA, Berman SM: Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm. Rep. 55(RR-11), 1-94 (2006).
39. Parkes R, Renton A, Meheus A, Laukamm-Josten U: Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int. J. STD AIDS 15(2), 73-88 (2004). (Pubitemid 38221754)
40. Rolfs RT, Joesoef MR, Hendershot EF et al.: A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N. Engl. J. Med. 337(5), 307-314 (1997).
41. Ghanem KG, Erbelding EJ, Cheng WW, Rompalo AM: Doxycycline compared with benzathine penicillin for the treatment of early syphilis. Clin. Infect. Dis. 42(6), E45-E49 (2006).
42. Hook EW 3rd, Behets F, Van Damme K et al.: A Phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J. Infect. Dis. 201(11), 1729-1735 (2010).
43. Lukehart SA, Godornes C, Molini BJ et al.: Macrolide resistance in Treponema pallidum in the United States and Ireland. N. Engl. J. Med. 351(2), 154-158 (2004).
44. Katz KA, Klausner JD: Azithromycin resistance in Treponema pallidum. Curr. Opin. Infect. Dis. 21(1), 83-91 (2008). Review of azithromycin-resistant syphilis and its consequences.
45. Mitchell SJ, Engelman J, Kent CK, Lukehart SA, Godornes C, Klausner JD: Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004. Clin. Infect. Dis. 42(3), 337-345 (2006).
46. Martin IE, Tsang RS, Sutherland K et al.: Molecular characterization of syphilis in patients in Canada: azithromycin resistance and detection of Treponema pallidum DNA in whole-blood samples versus ulcerative swabs. J. Clin. Microbiol. 47(6), 1668-1673 (2009).
47. Stamm LV: Global challenge of antibiotic-resistant Treponema pallidum. Antimicrob. Agents Chemother. 54(2), 583-589 (2010).
48. Martin IE, Gu W, Yang Y, Tsang RSW: Macrolide resistance and molecular types of Treponema pallidum causing primary syphilis in Shanghai, China. Clin. Infect. Dis. 49(4), 515-521 (2009).
49. Marra CM: Update on neurosyphilis. Curr. Infect. Dis. Rep. 11(2), 127-134 (2009). Excellent review of neurosyphilis, epidemiology, diagnostics and treatment.
50. Marra CM, Maxwell CL, Smith SL et al.: Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J. Infect. Dis. 189(3), 369-376 (2004).
51. Castro R, Prieto ES, da Luz Martins Pereira F: Nontreponemal tests in the diagnosis of neurosyphilis: an evaluation of the Venereal Disease Research Laboratory (VDRL) and the Rapid Plasma Reagin (RPR) tests. J. Clin. Lab. Anal. 22(4), 257-261 (2008).
52. Marra CM, Tantalo LC, Maxwell CL, Dougherty K, Wood B: Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals. Neurology 63(1), 85-88 (2004). (Pubitemid 38943783)
53. Marra CM, Tantalo LC, Sahi SK, Maxwell CL, Lukehart SA: CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis. Sex. Transm. Dis. 37(5), 283-287 (2010).
54. Libois A, De Wit S, Poll B et al.: HIV and syphilis: when to perform a lumbar puncture. Sex. Transm. Dis. 34(3), 141-144 (2007).
55. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA: Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clin. Infect. Dis. 48(6), 816-821 (2009).
56. Zetola NM, Engelman J, Jensen TP, Klausner JD: Syphilis in the United States: an update for clinicians with an emphasis on HIV coinfection. Mayo Clin. Proc. 82(9), 1091-1102 (2007).
57. Kent ME, Romanelli F: Reexamining syphilis: an update on epidemiology, clinical manifestations, and management. Ann. Pharmacother. 42(2), 226-236 (2008).
58. Vera JH, Parkes R, Goldmeier D: Current management of syphilis infection. Int. J. STD AIDS 20(11), 810 (2009).
59. Gitai LL, Jalali PS, Takayanagui OM: Neurosyphilis in the age of AIDS: clinical and laboratory features. Neurol. Sci. 30(6), 465-470 (2009).
60. Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW: Case definitions for public health surveillance. MMWR Recomm. Rep. 39(RR-13), 1-43 (1990).
61. Marra CM, Maxwell CL, Tantalo LC, Sahi SK, Lukehart SA: Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin. Infect. Dis. 47(7), 893-899 (2008).
62. Gray RT, Hoare A, Prestage GP, Donovan B, Kaldor JM, Wilson DP: Frequent testing of highly sexually active gay men is required to control syphilis. Sex. Transm. Dis. 37(5), 298-305 (2010). Excellent paper looking at control strategies for the current MSM syphilis epidemic.
63. Pialoux G, Vimont S, Moulignier A, Buteux M, Abraham B, Bonnard P: Effect of HIV infection on the course of syphilis. AIDS Rev. 10(2), 85-92 (2008).
64. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA: Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. Clin. Infect. Dis. 47(2), 258-265 (2008).
65. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA: Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS 22(10), 1145-1151 (2008).
66. Jin F, Prestage GP, Zablotska I et al.: High rates of sexually transmitted infections in HIV positive homosexual men: data from two community based cohorts. Sex. Transm. Infect. 83(5), 397-399 (2007).
67. Ogilvie GS, Taylor DL, Moniruzzaman A et al.: A population-based study of infectious syphilis rediagnosis in British Columbia, 1995-2005. Clin. Infect. Dis. 48(11), 1554-1558 (2009). Audit of syphilis cases showing re-infection is becoming increasingly common.
68. Backhouse J, Hudson B, Hamilton P, Nesteroff S: Failure of penicillin treatment of yaws on Karkar Island, Papua New Guinea. Am. J. Trop. Med. Hyg. 59(3), 388-392 (1998).
69. Lambert NL, Imrie J, Fisher MJ, Phillips A, Watson R, Dean G: Making sense of syphilis: beliefs, behaviours and disclosure among gay men recently diagnosed with infectious syphilis and the implications for prevention. Sex. Health 3(3), 155-161 (2006).
70. Bissessor M, Fairley CK, De Guingand D, Bradshaw CS, Chen MY: Delay in the diagnosis of early syphilis among men who have sex with men: need for greater community and health provider education. Int. J. STD AIDS 20(1), 52-53 (2009).
71. Stephens SC, Bernstein KT, McCright JE, Klausner JD: Dogs are talking: San Francisco's social marketing campaign to increase syphilis screening. Sex. Transm. Dis. 37(3), 173-176 (2010).
72. Ahrens K, Kent CK, Montoya JA et al.: Healthy penis: San Francisco's social marketing campaign to increase syphilis testing among gay and bisexual men. PLoS Med. 3(12), E474 (2006).
73. Vega MY, Roland EL: Social marketing techniques for public health communication: a review of syphilis awareness campaigns in 8 US cities. Sex. Transm. Dis. 32(Suppl.10), S30-S36 (2005).
74. Taylor M, Montoya JA, Cantrell R et al.: Interventions in the commercial sex industry during the rise in syphilis rates among men who have sex with men (MSM). Sex. Transm. Dis. 32(Suppl. 10), S53-S59 (2005).
75. Montoya JA, Kent CK, Rotblatt H, McCright J, Kerndt PR, Klausner JD: Social marketing campaign significantly associated with increases in syphilis testing among gay and bisexual men in San Francisco. Sex. Transm. Dis. 32(7), 395-399 (2005). Discusses the evaluation of the 'Healthy Penis' campaign supporting its effectiveness.
76. Koss C, Dunne E, Warner L: A systematic review of epidemiologic studies assessing condom use and risk of syphilis. Sex. Transm. Dis. 36(7), 401-405 (2009).
77. Aberg JA, Kaplan JE, Libman H et al.: Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin. Infect. Dis. 49(5), 651-681 (2009).
78. Taylor M, Prescott L, Brown J et al.: Activities to increase provider awareness of early syphilis in men who have sex with men in 8 cities, 2000-2004. Sex. Transm. Dis. 32(Suppl. 10), S24-S29 (2005).
79. Schmitt K, Bulecza S, George D, Burns TE, Jordahl L: Florida's multifaceted response for increases in syphilis among MSM: the Miami-Ft. Lauderdale initiative. Sex. Transm. Dis. 32(Suppl. 10), S19-S23 (2005).
80. Vidanapathirana J, Abramson MJ, Forbes A, Fairley C: Mass media interventions for promoting HIV testing: Cochrane systematic review. Int. J. Epidemiol. 35(2), 233-234 (2006).
81. Bissessor M, Fairley CK, Leslie D, Howley K, Chen MY: Frequent screening for syphilis as part of HIV monitoring increases the detection of early asymptomatic syphilis among HIV-positive homosexual men. J. Acquir. Immune Defic. Syndr. 55(2), 211-216 (2010). Audit showing how syphilis testing can be integrated successfully into HIV monitoring.
82. Klausner JD, Levine DK, Kent CK: Internet-based site-specific interventions for syphilis prevention among gay and bisexual men. AIDS Care 16(8), 964-970 (2004).
83. Ciesielski C, Kahn RH, Taylor M, Gallagher K, Prescott LJ, Arrowsmith S: Control of syphilis outbreaks in men who have sex with men: the role of screening in nonmedical settings. Sex. Transm. Dis. 32(Suppl. 10), S37-S42 (2005). Highlights the problems screening for a rare disease.
84. Lambert NL, Fisher M, Imrie J et al.: Community based syphilis screening: feasibility, acceptability, and effectiveness in case finding. Sex. Transm. Infect. 81(3), 213-216 (2005).
85. Knussen C, Flowers P: Notification of syphilis test results by telephone: acceptability ratings in a community-based sample of Scottish gay men. Int. J. STD AIDS 18(12), 827-828 (2007).
86. Tucker JD, Bu J, Brown LB, Yin YP, Chen XS, Cohen MS: Accelerating worldwide syphilis screening through rapid testing: a systematic review. Lancet Infect. Dis. 10(6), 381-386 (2010). Excellent review of the role of rapid testing in syphilis screening.
87. Lee D, Fairley CK, Cummings R, Bush M, Read T, Chen MY: Views of Australian men who have sex with men on rapid testing for syphilis and HIV. Presented at: Australasian Sexual Health Conference. Brisbane, Australia, 7-9 September 2009.
88. Klausner JD: Frequency of syphilis testing in HIV-infected patients: more and more often. Sex. Transm. Dis. 36(2), 86-87 (2009).
89. Bauer HM, Wohlfeiler D, Klausner JD, Guerry S, Gunn RA, Bolan G: California guidelines for expedited partner therapy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex. Transm. Dis. 35(3), 314-319 (2008).
90. McFarlane M, Kachur R, Klausner JD, Roland E, Cohen M: Internet-based health promotion and disease control in the 8 cities: successes, barriers, and future plans. Sex. Transm. Dis. 32(Suppl. 10), S60-S64 (2005).
91. Klausner JD, Wolf W, Fischer-Ponce L, Zolt I, Katz MH: Tracing a syphilis outbreak through cyberspace. JAMA 284(4), 447-449 (2000).
92. Rekart ML, Wong T, Wong E, Hutchinson K, Ogilvie G: The impact of syphilis mass treatment one year later: self-reported behaviour change among participants. Int. J. STD AIDS 16(8), 571-578 (2005).
93. Hibbs JR, Gunn RA: Public health intervention in a cocaine-related syphilis outbreak. Am. J. Public Health 81(10), 1259-1262 (1991).
94. Pourbohloul B, Rekart ML, Brunham RC: Impact of mass treatment on syphilis transmission: a mathematical modeling approach. Sex. Transm. Dis. 30(4), 297-305 (2003).
95. Touze JE, Debonne JM, Boutin JP: Current situation and future perspectives for malaria prophylaxis among travellers and military personnel. Bull. Acad. Natl Med. 191(7), 1293-1302 (2007).
96. Faucher JF, Hoen B, Estavoyer JM: The management of leptospirosis. Expert Opin. Pharmacother. 5(4), 819-827 (2004).
97. Hill DR, Ericsson CD, Pearson RD et al.: The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 43(12), 1499-1539 (2006).
98. Bratton RL, Whiteside JW, Hovan MJ, Engle RL, Edwards FD: Diagnosis and treatment of Lyme disease. Mayo. Clin. Proc. 83(5), 566-571 (2008).
99. Bilukha OO, Rosenstein N: Prevention and control of meningococcal disease. Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm. Rep. 54(RR-7), 1-21 (2005).
100. Fiore AE, Shay DK, Broder K et al.: Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm. Rep. 58(RR-8), 1-52 (2009).
101. Farley TA, Cohen DA, Kahn RH, Lolis S, Johnson G, Martin DH: The acceptability and behavioral effects of antibiotic prophylaxis for syphilis prevention. Sex. Transm. Dis. 30(11), 844-849 (2003).
102. O'Keefe B, Smith FB; Australian War Memorial: Medicine at War: Medical Aspects of Australia's Involvement in Southeast Asia 1950-1972. Allen & Unwin, in association with the Australian War Memorial, St Leonards, New South Wales, Australia, 224-227 (1994).
103. Kahn RH, Moseley KE, Johnson G, Farley TA: Potential for community-based screening, treatment, and antibiotic prophylaxis for syphilis prevention. Sex. Transm. Dis. 27(4), 188-192 (2000).
104. Cullen PA, Cameron CE: Progress towards an effective syphilis vaccine: the past, present and future. Expert Rev. Vaccines 5(1), 67-80 (2006).
105. Tomson FL, Conley PG, Norgard MV, Hagman KE: Assessment of cell-surface exposure and vaccinogenic potentials of Treponema pallidum candidate outer membrane proteins. Microbes Infect. 9(11), 1267-1275 (2007).
106. The Health in Men and Positive Health cohorts: A comparison of trends in the health and sexual behaviour of HIV-negative and HIV-positive gay men, 2002-2005. (2006) http://nchsr.arts.unsw.edu.au/media/File/HIM-PH.pdf
107. Pleasure and Sexual Health: The PASH Study www.nchecr.unsw.edu.au/ NCHECRweb.nsf/resources/TOMS/$file/PASH2009-final.pdf
108. Phase A of the National Gay Men's Syphilis Action Plan: modelling evidence and research on acceptability of interventions for controlling syphilis in Australia www.nchecr.unsw.edu.au/NCHECRweb.nsf/resources/Reports/ $file/SyphilisPhaseAReport.pdf